Allelic loss of 3 different tumor suppressor gene loci in benign and malignant endothelial tumors of the head and neck

Archives of Pathology and Laboratory Medicine

Volumn 130, Issue 8, 2006, Pages 1184-1187

  Domfeh, Akosua B ^a   Fichera, Michelle ^a   Hunt, Jennifer L ^a,b  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; RETINOBLASTOMA PROTEIN; WT1 PROTEIN;

ALLELIC IMBALANCE; ANGIOSARCOMA; ARTICLE; CAPILLARY ELECTROPHORESIS; CHROMOSOME 11P; CHROMOSOME 13Q; CHROMOSOME 17P; DNA EXTRACTION; ENDOTHELIUM CELL; GENE AMPLIFICATION; GENE LOCUS; GENE OVEREXPRESSION; GRANULATION TISSUE; HEAD AND NECK TUMOR; HEMANGIOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MICRODISSECTION; MOLECULAR MODEL; PATHOGENESIS; POLYMERASE CHAIN REACTION; TUMOR SUPPRESSOR GENE; VASCULAR DISEASE;

CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 13; CHROMOSOMES, HUMAN, PAIR 17; DNA, NEOPLASM; ENDOTHELIUM, VASCULAR; GENES, P53; GENES, RETINOBLASTOMA; GENES, TUMOR SUPPRESSOR; GENES, WILMS TUMOR; GENETIC MARKERS; GRANULATION TISSUE; HEAD AND NECK NEOPLASMS; HEMANGIOMA; HEMANGIOSARCOMA; HUMANS; LOSS OF HETEROZYGOSITY; MICRODISSECTION; MICROSATELLITE REPEATS;

EID: 33746674417     PISSN: 00039985     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Sturgis EM, Potter BO. Sarcomas of the head and neck region. Curr Opin Oncol. 2003;15:239-252.
2. Frick WG, McDaniel RK. Angiosarcoma of the tongue: report of a case. J Oral Maxillofac Surg. 1988;46:496-498.
3. Lanigan DT, Hey JH, Lee L. Angiosarcoma of the maxilla and maxillary sinus: report of a case and review of the literature. J Oral Maxillofac Surg. 1989; 47:747-753.
4. McRae RDR, Gatland DJ, McNab Jones RF, Khan S. Malignant transformation in a laryngeal hemangioma. Ann Otol Rhinol Laryngol. 1990;90:562-565.
5. Harrison D, Lund VJ. Vasoform tumors. In: Harrison D, Lund VJ, eds. Tumors of the Upper law. Edinburgh, Scotland: Churchill Livingstone; 1993:157-186.
6. Chen KTK, Hoffman KD, Hendricks EJ. Angiosarcoma following therapeutic irradiation. Cancer. 1979;44:2044-2048.
7. Narula AA, Vallis MP, El-Silimy OE, et al. Radiation-induced angiosarcomas of the nasopharynx. Eur J Surg Oncol. 1986;12:147-152.
8. Kuerbitz SJ, Beverly SP, Walsh WV, Kastan MB. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc Natl Acad Sci USA. 1992; 89:7491-7495.
9. Donehower LA, Harvey M, Slagle BL, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumors. Nature. 1992; 356:215-221.
10. Naka N, Tomita Y, Nakanishi H, et al. Mutations of p53 tumor-suppressor gene in angiosarcoma. Int J Cancer. 1997;71:952-955.
11. Zietz C, Rössle M, Hass C, et al. MDM-2 oncoprotein overexpression, p53 gene mutation, and VECF upregulation in angiosarcomas. Am J Pathol. 1998;153: 1425-1433.
12. Kimura M, Cao X, Patel S, Aviv A. Survival advantage of cultured human vascular endothelial cells that lost chromosome 13. Chromosoma. 2004;112: 317-322.
13. Fedok FG, Levin RJ, Maloney ME, Tipirneni K. Angiosarcoma: current review. Am J Otolaryngol. 1999;20:223-231.
14. Holden CA, Spittle MF, Jones EW. Angiosarcoma of the face and scalp, prognosis and treatment. Cancer. 1987;59:1046-1057.
15. Mark RJ, Poen JC, Tran LM, Fu YS, Juilliard GF. Angiosarcoma: a report of sixty-seven patients and a review of the literature. Cancer. 1996;77:2400-2406.
16. Aust MR, Olsen KD, Lewis JE, et al. Angiosarcomas of the head and neck: clinical and pathologic characteristics. Ann Otol Rhinol Laryngol. 1997;106:943-951.
17. Mark RJ, Poen J, Tran LM, et al. Postirradiation sarcomas: a single-institution study and review of the literature. Cancer. 1994;73:2653-2662.
18. Williamson IG, Ramsden RT. Angiosarcoma of maxillary antrum: association with vinyl chloride exposure. J Laryngol Otol. 1988;102:464-467.
19. Benbenisty KM, Lang PG, Maize JC. Extensive angiosarcoma on chronically sun-damaged skin. Am J Clin Dermatol. 2004;5:53-55.
20. Amo Y, Masuzawa M, Hamada Y, Katsuoka K. Expression of vascular endothelial growth factor in a human hemangiosarcoma cell line (ISO-HAS). Arch Dermatol Res. 2001;293:296-301.
21. Ueda T, Naka N, Nakano Y, et al. Overexpression of Wilm's tumor gene WT1 in human bone and soft tissue sarcomas. Cancer Sci. 2003;94:271-276.
22. Iida A, Tananka T, Nakamura Y. High density SNP map of human ITR, a gene associated with vascular remodeling. J Human Genet. 2003;48:170-172.